bd 1047 has been researched along with nisoxetine in 1 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (nisoxetine) | Trials (nisoxetine) | Recent Studies (post-2010) (nisoxetine) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 316 | 2 | 62 |
| Protein | Taxonomy | bd 1047 (IC50) | nisoxetine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.0079 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.0079 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.4 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0131 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0083 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.8628 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.65 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horishita, T; Inagaki, H; Kawasaki, T; Obara, G; Sata, T; Takahashi, K; Toyohira, Y; Tsutsui, M; Ueno, S; Yanagihara, N | 1 |
1 other study(ies) available for bd 1047 and nisoxetine
| Article | Year |
|---|---|
Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells.
Topics: Adrenal Medulla; Analgesics, Opioid; Animals; Cattle; Cell Line; Cell Membrane; Cells, Cultured; Ethylenediamines; Fluoxetine; Gene Expression; Humans; Naltrexone; Narcotic Antagonists; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pentazocine; Radionuclide Imaging | 2013 |